about
Stabilization of resveratrol in blood circulation by conjugation to mPEG and mPEG-PLA polymers: investigation of conjugate linker and polymer composition on stability, metabolism, antioxidant activity and pharmacokinetic profileTailoring structure-function properties of L-asparaginase: engineering resistance to trypsin cleavageSynthesis and structural analysis of polyester prodrugs of norfloxacin.Polyethylene glycol (PEG) linked to near infrared (NIR) dyes conjugated to chimeric anti-carcinoembryonic antigen (CEA) antibody enhances imaging of liver metastases in a nude-mouse model of human colon cancer.A poloxamine-polylysine acrylate scaffold for modular tissue engineering.PEGylation of bovine serum albumin using click chemistry for the application as drug carriers.Optimizing anti-gene oligonucleotide 'Zorro-LNA' for improved strand invasion into duplex DNA.Peripherally cross-linking the shell of core-shell polymer micelles decreases premature release of physically loaded combretastatin A4 in whole blood and increases its mean residence time and subsequent potency against primary murine breast tumors aCan formulation and drug delivery reduce attrition during drug discovery and development-review of feasibility, benefits and challenges.Dendrimers for pharmaceutical and biomedical applications.Synthetic polymers as drug-delivery vehicles in medicineAssociation with Amino Acids Does Not Enhance Efficacy of Polymerized Liposomes As a System for Lung Gene Delivery.PEGylated bioactive molecules in biodegradable polymer microparticles.Surface-engineered dendrimers: a solution for toxicity issues.Strategies for delivery of therapeutics into the central nervous system for treatment of lysosomal storage disorders.Lactoferrin delivery systems: approaches for its more effective use.Recent developments in protein and peptide parenteral delivery approaches.Effects of branching architecture and linker on the activity of hyperbranched polymer-drug conjugates.New cyclodextrin bioconjugates for active tumour targeting.Synthesis and characterization of positively charged tPA as a prodrug using heparin/protamine-based drug delivery systemOptimization of physicochemical parameters influencing the fabrication of protein-loaded chitosan nanoparticles.Immunoconjugates of soybean Bowman-Birk protease inhibitor as targeted antitumor polymeric agents.Evaluation of photoluminescence properties of some poly(ethylene glycol)-supported coumarin derivatives.Polymerization of cyclic esters initiated by carnitine and tin (II) octoate.A 'photorelease, catch and photorelease' strategy for bioconjugation utilizing a p-hydroxyphenacyl group.Penicillin V-conjugated PEG-PAMAM star polymers.Production of PEGylated ProteinsAccelerated pharmaceutical protein development with integrated cell free expression, purification, and bioconjugation
P2860
Q28544851-3619D615-26AF-4046-B646-1A2343A632F0Q33274867-21A5472A-A981-4317-BB9E-D480556D158CQ33318754-EAE9F14F-ADB0-42BF-B15F-A76A104D1F0DQ33654731-221E4873-9429-486C-AD89-389F3DFD7CB7Q33767177-525B814D-D7A6-4E9C-A0BA-43D0CE130B51Q34139643-C1BCBDCE-3EDA-46AA-89F0-FC2887539378Q34559630-FB35CE11-5644-4CEB-AE3E-931E6FC61AD0Q35085896-242DB79E-D6E7-4B1E-8825-3FB9F7719FF6Q36111924-00A50385-A81B-4A0E-B780-B2B4C9A6AD46Q36367723-38A46CFC-314E-416A-B22C-0DBE90FFE612Q36662516-07E9F48C-56D6-4DD7-9406-EC20D9D8412BQ36834460-05A3E84E-A268-4BE9-B819-A5BA09B4ABCCQ36922266-19D29FB0-E74F-4CB6-A89E-6A4C21A8989AQ37372870-C9A9F350-7742-4F7F-BF68-48C4057BD10FQ37672410-CB10E119-F961-4304-836A-426A12061C9CQ37927094-ED347BC6-2F10-43E7-8E3C-4848C0CC2731Q38193174-7EBED3E1-2941-4C85-80D4-F475745FFE33Q39858988-1DDFB623-FB94-4DC6-8CA3-798015D50EE3Q40110851-ED5F06D9-75C8-4FCB-8D7A-858F1A738295Q42564637-D4083C48-515A-4F1D-A416-A037534386E3Q43259026-9C9A8637-7C30-49A1-AEE1-2730D43B2984Q44597241-D8CA4CAD-7FEC-4F30-AFB1-1A93CD3D490CQ46079051-F05FB340-4467-4EF8-8D9B-183B69FB3752Q46123452-6DDE08F8-31DC-4879-90FB-482B16AC5140Q48279771-FB87EB8B-742E-4A2A-94BD-CC98AD9AA6E3Q51788107-19B5E284-1521-4C28-97FD-7D9A97A2D2BDQ57635944-A32D0E45-75BE-4E52-9A88-50BA3BFAD8F0Q58790935-BC7AF11B-B62E-4A84-B7F1-AFF3126D72DD
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Bioconjugation in pharmaceutical chemistry.
@ast
Bioconjugation in pharmaceutical chemistry.
@en
type
label
Bioconjugation in pharmaceutical chemistry.
@ast
Bioconjugation in pharmaceutical chemistry.
@en
prefLabel
Bioconjugation in pharmaceutical chemistry.
@ast
Bioconjugation in pharmaceutical chemistry.
@en
P1433
P1476
Bioconjugation in pharmaceutical chemistry
@en
P2093
Veronese FM
P304
P356
10.1016/S0014-827X(99)00066-X
P577
1999-08-01T00:00:00Z